CellFE is a venture-backed company with a mission to make advanced therapies accessible to all by transforming the way gene therapies are manufactured. The company uses a microfluidics-based cell engineering platform that can be adapted universally to enable low-cost, high-yield manufacturing of gene therapies at scale.
CellFE’s executive team is composed of members who bring strong expertise in the theoretical and practical aspects of the technology, as well as experience in leadership and business operations. CellFE’s research and development efforts are led by world-class scientists who are passionate about using microfluidics to transform how gene therapies are manufactured.
Microfluidic Transfection Device is Poised to Remove Current Transfection Limitations for Gene Therapy Applications
CellFE has recently announced the development of a microfluidic platform that has the potential to remove many of the current bottlenecks in transfection-dependent production processes....Continued